Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ: ANGO )

9.640 +0.290 (+3.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
From AngioDynamics, Inc.
Via Business Wire
Preview: AngioDynamics's Earnings
Via Benzinga
AngioDynamics - Undervalued Gem In Med Tech: Analyst Eyes Stellar Growth With A 'Buy' Stance
H.C. Wainwright initiated coverage on AngioDynamics Inc (NASDAQ: ANGO), noting that the company is debt-free and significantly undervalued compared to peers in a growing market. 
Via Benzinga
Why AngioDynamics Stock Popped on Monday
AngioDynamics has fascinating technology, but few prospects for profits. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga
AngioDynamics's Earnings: A Preview
Via Benzinga
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
From AngioDynamics, Inc.
Via Business Wire
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Performance Food Group, Stride, Progressive, H&R Block And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones gaining close to 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Shares of AngioDynamics Rose Friday
The medical technology company sold some of its assets to pay down its debt. 
Via The Motley Fool
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
From AngioDynamics, Inc.
Via Business Wire
Should Growth Investors Buy This Revolutionary Small-Cap Stock?
The medical devices company is taking an exciting approach to treating some of the most complex diseases. 
Via The Motley Fool
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
From AngioDynamics, Inc.
Via Business Wire
Why Are AngioDynamics Shares Trading Lower Today
AngioDynamics Inc (NASDAQ: ANGO) has reported a Q4 FY23 adjusted EPS of $0.02, in line with the consensus EPS higher than $0.01 a year ago. 
Via Benzinga
Small Caps Lift Stock Futures As Traders Await Inflation Data: Analyst Says 'Now Is A Good Time' To Diversify Portfolios
Via Benzinga
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Optimism Improves Ahead Of Inflation Data
The CNN Money Fear and Greed index showed some improvement in overall sentiment among U.S. investors on Tuesday. U.S. stocks closed higher on Tuesday ahead of this week’s key inflation data. The... 
Via Benzinga
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
From AngioDynamics, Inc.
Via Business Wire
Future Of Merit Medical Systems: Analyst Predictions On Revenue Growth And Operating Margin Improvement
Needham analyst Mike Matson reiterated a Buy rating on the shares of Merit Medical Systems, Inc. (NASDAQ: MMSI),  
Via Benzinga
AngioDynamics Divests Dialysis Portfolio And Biopsy Product Line To Merit Medical Systems For $100M
AngioDynamics, Inc. (NASDAQ: ANGO)  
Via Benzinga
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
From AngioDynamics, Inc.
Via Business Wire
Top 5 Health Care Stocks That Are Preparing To Pump In Q2
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
Via Benzinga
AngioDynamics to Present at the Needham Virtual Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Wall Street Thinks This Small-Cap Stock Can Double in Value
Analysts are projecting a huge rebound from this beaten-down stock in the next 12 months. 
Via The Motley Fool
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.